anmelden
SPI Healthcare
3.597,97
PKT
+5,14
PKT
+0,14
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SPI Healthcare-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 26.01.05 | Lonza Reduce | Sarasin Research | |
| 25.01.05 | Novartis Outperform | Goldman Sachs | |
| 25.01.05 | Lonza Overweight | JP Morgan | |
| 25.01.05 | Novartis Halten | LB Baden-Württemberg | |
| 25.01.05 | Novartis Buy | Helvea | |
| 24.01.05 | Novartis Overweight | Prudential Securities | |
| 24.01.05 | Novartis Neutral | Sarasin Research | |
| 25.01.05 | Novartis Neutral | Sarasin Research | |
| 24.01.05 | Straumann Outperform | Credit Suisse First Boston | |
| 21.01.05 | Roche Buy | Sarasin Research | |
| 24.01.05 | Lonza Reduce | Sarasin Research | |
| 24.01.05 | Novartis Kaufen | Hamburger Sparkasse | |
| 21.01.05 | Novartis Kaufen | Helaba Trust | |
| 24.01.05 | Novartis Neutral | HypoVereinsbank | |
| 20.01.05 | Novartis Hold | SEB | |
| 20.01.05 | Novartis Neutral | Sarasin Research | |
| 20.01.05 | Novartis Akkumulieren | Independent Research | |
| 21.01.05 | Novartis Buy | Helvea | |
| 19.01.05 | Novartis Equal-weight | Morgan Stanley | |
| 19.01.05 | Tecan (N) Reduce | Helvea | |
| 19.01.05 | Straumann Accumulate | Helvea | |
| 21.01.05 | Novartis Kaufen | Helaba Trust | |
| 18.01.05 | Novartis Buy | AG Edwards | |
| 18.01.05 | Novartis Outperform | Bear Stearns | |
| 18.01.05 | Novartis Buy | Merrill Lynch | |
| 18.01.05 | Lonza Buy | Helvea | |
| 18.01.05 | Siegfried Neutral | Helvea | |
| 18.01.05 | Roche Buy | Merrill Lynch | |
| 18.01.05 | Novartis Buy | Merrill Lynch | |
| 18.01.05 | Novartis Buy | Sarasin Research | |
| 18.01.05 | Novartis Akkumulieren | Independent Research | |
| 17.01.05 | Lonza Reduce | Sarasin Research | |
| 17.01.05 | Novartis Sector Outperform | Vontobel | |
| 14.01.05 | Novartis Kaufen | Helaba Trust | |
| 14.01.05 | Novartis Overweight | Lehman Brothers | |
| 18.01.05 | Novartis Empfehlungsliste | Erste Bank | |
| 17.01.05 | Sonova Outperform | Credit Suisse First Boston | |
| 17.01.05 | Tecan (N) Neutral | Credit Suisse First Boston | |
| 17.01.05 | Basilea Pharmaceutica Outperform | Credit Suisse First Boston | |
| 18.01.05 | Straumann Outperform | Credit Suisse First Boston |